Skip to main content
SpringerLink
Log in
Book cover

Hepatocellular Carcinoma pp 467–475Cite as

Resection of Hepatocellular Carcinoma

  • Chapter
  • First Online:

  • 2069 Accesses

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Surgery is the mainstay of HCC treatment.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Llovet JM, Fuster J, Bruix J. Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–40.

    Article  CAS  PubMed  Google Scholar 

  2. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western cnter. Ann Surg. 1999;229:790–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Sturg. 1997;173:358–65.

    Article  CAS  Google Scholar 

  4. Llovet JM, Burroghs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  5. Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, et al. Long-term survival of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single center experience. Ann Surg. 2013;257:506–11.

    Article  PubMed  Google Scholar 

  6. Soubrane O, Goumard C, Laurent A, Tranchart H, Truant S, Gayet B, et al. Laparoscopic resection of hepatocellular carcinoma: a French survey in 351 patients. HPB. 2014;16:357–65.

    Article  PubMed  Google Scholar 

  7. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients impaired hepatic function. Surgery. 1984;95:586–92.

    CAS  PubMed  Google Scholar 

  8. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589–94.

    Article  CAS  PubMed  Google Scholar 

  9. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC 2nd, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multiinstitutional analysis. J Am Col Surg. 2011;212:638–48.

    Article  Google Scholar 

  10. Bruix J, Castells A, Bosch J, eu F, Fuster J, Gasrcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018–22.

    Google Scholar 

  11. Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014;260:329–40.

    Article  PubMed  Google Scholar 

  12. Ioannou G, Splan M, Weiss M, McDonald G, Beretta L, Lee S. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2007;5:938–45.

    Article  PubMed  Google Scholar 

  13. Ng KK, Vauthey JN, Pawlick TM, Lauwers GY, Regimbeau HM, Belghiti J, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 2005;12:364–73.

    Article  PubMed  Google Scholar 

  14. Yin L, Li H, Li AJ, Lau WY, Pan ZY, Lai EC, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol. 2014;61:82–8.

    Article  PubMed  Google Scholar 

  15. Lin CY, Chen JH, Liang JA, Lin CC, Jeng LB, Kao CH. 18-FDG-PET or PET/CT for detecting extrahepatic metastases of recurrent hepatocellular carcinoma: a systematic review and metaanalysis. Eur J Radiol. 2012;81:2417–22.

    Article  PubMed  Google Scholar 

  16. Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB. Role of FDG-PET in evaluation and stagin of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologo = ical grade. Int Surg. 2010;95:67–75.

    CAS  PubMed  Google Scholar 

  17. Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jachavala J. Adde value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol. 2013;7:8357–65.

    Article  Google Scholar 

  18. Young AL, Malik HZ, Abu-Hilal M, Guthrie JA, Wyatt J, Prasad KR, et al. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Col Surg. 2007;205:453–62.

    Article  Google Scholar 

  19. Bruix J, Raoul JL, Sherman M, Mazzaferro V, Bolondi L, Craxi A, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalysis of a phase 3 trial. J Hepatol. 2012;57:821–9.

    Article  CAS  PubMed  Google Scholar 

  20. Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, et al. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinomawith portal vein invasion. J Gastroenterol Hepatol. 2009;24:806–14.

    Article  PubMed  Google Scholar 

  21. Chung JW, Park JH, Han JK, Choi BI, Han MC. Hepatocellular carcinoma and portal vein invasion: results of treatment with transarterial oily chemoembolization. Am J Roentgenol. 1995;165:315–21.

    Article  CAS  Google Scholar 

  22. Roayaie S, Jibara G, Taouli B, Schwartz M. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol. 2013;20:3754–60.

    Article  PubMed  Google Scholar 

  23. Pawlick TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005;137:403–10.

    Article  Google Scholar 

  24. Inoue Y, Hasegawa K, Ishizawa T, Aoki T, Sano K, Beck Y, et al. Is there an difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery. 2009;145:9–19.

    Article  PubMed  Google Scholar 

  25. Fan J, Zhou J, Wu ZQ, Qiu SJ, Wang XY, Shi YH, et al. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombus. World J Gastroenterol. 2005;11:1215–9.

    Article  PubMed Central  Google Scholar 

  26. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12:966–71.

    Article  PubMed  Google Scholar 

  27. The SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointestinal Surg. 2005;9:1207–15.

    Article  Google Scholar 

  28. Fan ST, Lai EC, Lo CM, Wong J. Hospital mortality of major haptectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995;130:198–203.

    Article  CAS  PubMed  Google Scholar 

  29. Lam CM, Fan ST, Lo CM, Wong J. Major hepatectomy for hepatocellular carcinoma I patients with unsatisfactory indocyanine green clearance test. Br J Surg. 1999;86:1012–7.

    Article  CAS  PubMed  Google Scholar 

  30. Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective. J Hepatobiliary Pancreat Sci. 2010;17:380–4.

    Article  PubMed  Google Scholar 

  31. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208–17.

    PubMed  PubMed Central  Google Scholar 

  32. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49–57.

    Article  PubMed  Google Scholar 

  33. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;213:201–9.

    Article  Google Scholar 

  34. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolization before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091–8.

    Article  CAS  PubMed  Google Scholar 

  35. Hwang S, Ha TY, Ko GY, Kwon DI, Song GW, Jung DH, et al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg 2015 Aug 25. Epub ahead of print.

    Google Scholar 

  36. Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, et al. Radiation lobectomy: time-dependant analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013;59:1029–36.

    Article  PubMed  Google Scholar 

  37. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261–9.

    Article  PubMed  Google Scholar 

  38. Chang CM, Yin WY, Su YC, Wei CK, Lee CH, Juang SY, et al. Preoperative risk score predicting 90-day mortality after liver resection in a population-based study. Medicine (Baltimore). 2014;93:e59.

    Article  Google Scholar 

  39. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology. 1994;106:1618–24.

    Article  CAS  PubMed  Google Scholar 

  40. Vauthey J, Lauwers G, Esnaola N, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002;20:1527–36.

    Article  PubMed  Google Scholar 

  41. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850–5.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Zhou Y, Xu D, Wu L, Li B. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langebecks Arch Surg. 2011;396:1109–17.

    Article  Google Scholar 

  43. Cuccetti A, Cescon M, Ercolani G, Bigonzi E, Torzilli G, Pinna AD. A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Ann Surg Oncol. 2012;19:3697–705.

    Article  Google Scholar 

  44. Regimbeau JM, Kianmanesh R, Farges O, Dandero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellullar carcinoma. Surgery. 2002;131:311–7.

    Article  PubMed  Google Scholar 

  45. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245:36–43.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Liu CI, Fan ST, Lo CM, Tung-Ping Poon R, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 2000; 232:25–31.

    Google Scholar 

  47. Liu CI, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244:194–203.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001;193:109–11.

    Article  CAS  PubMed  Google Scholar 

  49. Katz SC, Scia J, Liau KH, Gonen M, Rou L, Jarnagin WR, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249:617–23.

    Article  PubMed  Google Scholar 

  50. Ishizaki Y, Yoshimoto J, Miwa K, Sugo H, Kawasaki S. Safety of prolonged intermittent pringle maneuver during hepatic resection. Arch Surg. 2006;141:649–53.

    Article  PubMed  Google Scholar 

  51. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Yu WC, et al. Tolerance of the liver to intermittent Pringle maneuver in hepatectomy for liver tumors. Arch Surg. 1999;134:533–9.

    Article  CAS  PubMed  Google Scholar 

  52. Ker CG, Chen JS, Kuo KK, Chuang SC, Wang SJ, Chang WC, et al. Liver surgery for hepatocellular carcinoma: laparoscopic versus open approach. Int J Hepatol 2011;2011:596792 [PMID: 21994865 doi:10.46061/2011/596792.

  53. Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gothda N, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci 2015 Jun 22. doi:10.1002/jhpb.276 [epub ahead of print].

  54. Twaij A, Pucher PH, Sodergren MH, Gall T, Darzi A, Jiao LR. Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis. World J Gastroenterol. 2014;20:8274–81.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Yamashita Y, Ikeda T, Kurihara T, Yoshida Y, Takeishi K, Itoh S, et al. Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single center experience over a 10-year period. J Am Coll Surg. 2014;219:1117–23.

    Article  PubMed  Google Scholar 

  56. Lai EC, Yang GP, Tang CN. Robot-assisted laparoscopic liver resection for heaptocellular carcinoma: short-term outcome. Am J Surg. 2013;205:697–702.

    Article  PubMed  Google Scholar 

  57. Vannarecci G, Laurenzi A, Levi Sandri GB, Busi Rizzi E, Cristofaro M, Montalbano M, et al. The ALPPS procedure for hepatocellular carcinoma. Eur J Surg Oncol. 2014;40:982–8.

    Article  Google Scholar 

  58. Choi D, Lim HK, Joh JW, Kim SJ, Kim MJ, Rhim H, et al. Combined hepatectomy and radiofrequency ablation for multifocal hepatocelluar carcinoma: long-term follow up results and prognostic factors. Ann Surg Oncol. 2007;14:3510–8.

    Article  PubMed  Google Scholar 

  59. Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl. 2004;10:S46–52.

    Article  PubMed  Google Scholar 

  60. Dokmak S, Fteriche FS, Borscheid R, Cauchy F, Farges O, Belghiti J. 2012 liver resections in the 21st century: we are far from zero mortality. HPB (Oxford). 2013;15:908–15.

    Article  Google Scholar 

  61. Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, et al. Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol. 2014;20:14381–92.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Yang T, Li L, Zhong Q, Lau WY, Zhang H, Huang X, et al. Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg. 2013;37:23094–401.

    Google Scholar 

  63. Hanna EM, Martinie JB, Swan RZ, Iannitti DA. Fibrin sealants and topical agents in hepatobiliary and pancreatic surgery: a critical appraisal. Langenbecks Arch Surg. 2014;399:825–35.

    Article  PubMed  Google Scholar 

  64. Yoshiya S, Shirabe K, Nakagarawa H, Soejima Y, Yoshizumi T, Ikegami T, et al. Portal vein thrombosis after hepatectomy. World J Surg. 2014;38:1491–7.

    Article  PubMed  Google Scholar 

  65. European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56:908–43.

    Google Scholar 

  66. Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, et al. Differences in surgical outcomes between hepatitis B- and hepatitis C- related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg. 2014;260:650–6.

    Article  PubMed  Google Scholar 

  67. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678–86.

    Article  PubMed  Google Scholar 

  68. Hsu YC, Ho HJ, Wu MS, Lin JT, Wu CY. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology. 2013;58:150–7.

    Article  CAS  PubMed  Google Scholar 

  69. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, MaedaT Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71–6.

    Article  CAS  PubMed  Google Scholar 

  70. Capussotti L, Muratore A, Amisano M, Polastri R, Bouzari H, Massucco P. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—a European single center experience. Eur J Surg Oncol. 2005;31:986–93.

    Article  CAS  PubMed  Google Scholar 

  71. Franssen B, Jibara G, Tabrizian P, Schwartz ME, Roayaie S. Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2014;16:830–5.

    Article  Google Scholar 

  72. Xhen X, Zhang B, Yin X, Ren Z, Qiu S, Zhou J. Lipiodolized transarterial chemoembilzation in hepatocellular carcinoma patients after curative resection. J Cancer Res Clin Oncol. 2013;139:773–81.

    Article  Google Scholar 

  73. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolizatin for resectable large hepatocellular carcinoma. Ann Surg. 2009;249:195–202.

    Article  PubMed  Google Scholar 

  74. Xia Y, Qiu Y, Li J, Shi L, Wang K, Xi T, et al. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Ann Surg Oncol. 2010;17:3137–44.

    Article  PubMed  Google Scholar 

  75. Bruix J, Takayama Tm Mazzaferro V, Chau GY, Yang J, Kudo M, et al. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomized, double blind, placebo controlled trial. Lancet Oncol 2015 Sep 8. pii: S1470–2045(15)00198-9. doi:10.1016/S1470-2045(15)00198-9. [Epub ahead of print].

    Google Scholar 

  76. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.

    Article  PubMed  Google Scholar 

  77. Roayaie S, Bassi D, Tarchi P, Labow D, Schwartz M. Second hepatic resection for recurrent hepatocellular cancer: a western experience. J Hepatol. 2011;55:346–50.

    Article  PubMed  Google Scholar 

  78. Marin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol. 2003;47:13–27.

    Article  PubMed  Google Scholar 

  79. Kobayashi A, Kawasaki S, Miyagawa S, Miwa S, Noike T, Takagi S, et al. Results of 404 hepatic resection including 80 repeat hepatectomies for hepatocellular carcinoma. Hepatogastroenterology. 2006;53:736–41.

    PubMed  Google Scholar 

  80. Minigawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg. 2003;238:703–10.

    Article  Google Scholar 

  81. Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatociliary Pancreat Surg. 2001;8:410–6.

    Article  CAS  Google Scholar 

  82. Chrqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable heaptocellular carcinoma: lontg-term survival and role of secondary liver transplantation. Ann Surg. 2009;250:738–46.

    Article  Google Scholar 

  83. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg. 1998;85:1198–200.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Surgery Unit, Department Surgery, Tel-Aviv Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Nir Lubezky, Yaacov Goykhman, Richard Nakache & Ido Nachmany

Authors
  1. Nir Lubezky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yaacov Goykhman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Nakache
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ido Nachmany
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dokuz Eylul University, Izmir Biomedicine and Genome Center Dokuz Eylul University, Izmir, Izmir, Turkey

    Brian I. Carr

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lubezky, N., Goykhman, Y., Nakache, R., Nachmany, I. (2016). Resection of Hepatocellular Carcinoma. In: Carr, B. (eds) Hepatocellular Carcinoma. Current Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-34214-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34214-6_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34212-2

  • Online ISBN: 978-3-319-34214-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation